Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Teneobio
Teneobio
Amgen stops trial of Teneobio cancer candidate, taking $650M BiTE out of earnings
Fierce Biotech
Tue, 10/31/23 - 10:19 am
Amgen
earnings
Teneobio
bispecifics
Biopharma needs a biggie to avoid a down deal year
EP Vantage
Thu, 10/7/21 - 11:07 am
M&A
Merck
Acceleron
Sanofi
Translate Bio
Amgen
Teneobio
Pfizer
Trillium
Perrigo
HRA Pharma
Amgen pays $900M for Teneobio and bets bigger on next-gen antibody drugs
BioPharma Dive
Wed, 07/28/21 - 07:22 pm
Amgen
M&A
Teneobio
cancer
antibodies
AbbVie gains option to Teneobio BCMA program
BioCentury
Mon, 02/11/19 - 08:04 pm
AbbVie
Teneobio
TNB-383B
Multiple Myeloma